Geoffrey M. Parker Insider Trading $CCXI ChemoCentryx, Inc.
Get free email notifications about insider trading for Geoffrey M. Parker.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Geoffrey M. Parker. Geoffrey M. Parker is Director in GENOMIC HEALTH INC ($GHDX) and Director in SUNESIS PHARMACEUTICALS INC ($SNSS) and Director in GENOPTIX INC ($GXDX) and Executive Vice President & CFO in Anacor Pharmaceuticals, Inc. ($ANAC) and Director in ChemoCentryx, Inc. ($CCXI) and Director in PERRIGO Co plc ($PRGO) and CFO and EVP in Tricida, Inc. ($TCDA) and Chief Fin. Officer and EVP in Tricida, Inc. ($TCDA) and Chief Fin. Officer and Sr. VP in Tricida, Inc. ($TCDA).
Geoffrey M. Parker in ChemoCentryx, Inc.
Trading Symbol: CCXIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Geoffrey M. Parker: Director
Holdings: 42,690 shares
Current Value: $284,742
Latest Transaction: Mar 08 2021
$CCXI Market Capitalization: $309.30M
$CCXI Previous Close: $6.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Geoffrey M. Parker in ChemoCentryx, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANAC, CCXI, GHDX, GXDX, PRGO, TCDA, SNSS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 08 2021 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 55.89 | 13,330 | 744,974 | 12,690 | 26 K to 12.7 K (-51.23 %) |
Mar 08 2021 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 56.78 | 16,670 | 946,494 | 26,020 | 42.7 K to 26 K (-39.05 %) |
Mar 08 2021 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 60.20 | 1,910 | 114,980 | 42,690 | 44.6 K to 42.7 K (-4.28 %) |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 7,724 | 0 | 0 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 4,660 | 0 | 4,660 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 59.73 | 2,888 | 172,500 | 2,888 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 7,724 | 0 | 111,913 | 104.2 K to 111.9 K (+7.41 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 38.21 | 860 | 32,863 | 49,600 | 50.5 K to 49.6 K (-1.70 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 37.40 | 13,959 | 522,008 | 50,460 | 64.4 K to 50.5 K (-21.67 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 36.72 | 9,181 | 337,100 | 64,419 | 73.6 K to 64.4 K (-12.47 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 35.32 | 2,801 | 98,932 | 73,600 | 76.4 K to 73.6 K (-3.67 %) |
Mar 25 2020 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 34.43 | 3,199 | 110,147 | 76,401 | 79.6 K to 76.4 K (-4.02 %) |
Dec 04 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 6.00 | 31,990 | 191,940 | 0 | |
Dec 04 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 6.00 | 31,990 | 191,940 | 104,189 | 72.2 K to 104.2 K (+44.31 %) |
Jun 03 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 6.00 | 18,010 | 108,060 | 31,990 | |
Jun 03 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 12.00 | 12,815 | 153,806 | 72,199 | 85 K to 72.2 K (-15.07 %) |
Jun 03 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 6.00 | 18,010 | 108,060 | 85,014 | 67 K to 85 K (+26.88 %) |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 11.60 | 12,287 | 142,529 | 12,287 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 7,724 | 0 | 7,724 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 8,421 | 0 | 0 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 8,421 | 0 | 67,004 | 58.6 K to 67 K (+14.37 %) |
May 30 2018 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 12,912 | 0 | 0 | |
May 30 2018 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 12,912 | 0 | 58,583 | 45.7 K to 58.6 K (+28.27 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 12.94 | 13,352 | 172,775 | 13,352 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 8,421 | 0 | 8,421 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 12.94 | 13,352 | 172,775 | 13,352 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 8,421 | 0 | 8,421 | |
May 30 2017 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 20,362 | 0 | 0 | |
May 30 2017 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 12,912 | 0 | 12,912 | |
May 30 2017 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 20,362 | 0 | 45,671 | 25.3 K to 45.7 K (+80.45 %) |
May 27 2016 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 20,362 | 0 | 20,362 | |
May 24 2016 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 11,795 | 0 | 0 | |
May 24 2016 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 11,795 | 0 | 25,309 | 13.5 K to 25.3 K (+87.28 %) |
May 13 2016 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | P | 4.03 | 40,000 | 161,388 | 99,600 | 59.6 K to 99.6 K (+67.11 %) |
Jan 11 2016 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | P | 4.63 | 20,000 | 92,512 | 59,600 | 39.6 K to 59.6 K (+50.51 %) |
Dec 14 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | P | 7.30 | 4,621 | 33,724 | 39,600 | 35 K to 39.6 K (+13.21 %) |
Dec 14 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | P | 7.23 | 15,379 | 111,202 | 34,979 | 19.6 K to 35 K (+78.46 %) |
May 29 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 7.51 | 13,513 | 101,515 | 13,514 | 27 K to 13.5 K (-50.00 %) |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 27,027 | 0 | 0 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 11,795 | 0 | 11,795 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 27,027 | 0 | 27,027 | 0 to 27 K |
Page: 1